Continuous extradural analgesia is practised widely to relieve pain in labour. However, intermittent "top-ups" of local anaesthetic agents cause "surges" of calls upon medical and midwifery staff and, occasionally, marked changes in maternal cardiovascular function. Previous studies have shown the effectiveness of a continuous infusion with either 0.25% or 0.375% bupivacaine although frequent manipulation of the patient's posture was required to optimize pain relief (Glover, 1977; Evans and Carrie, 1979; Matouskova, Hanson and Elmen, 1979; Davies and Fettes, 1981; Taylor, 1983) . This approach appears to offer better haemodynamic stability, and should avoid delay in topping-up when anaesthetic or midwifery staff are busy. However, the potential risk of a dural puncture by the catheter during infusion remains a cause for concern. Hence, a compromise between efficacy and safety has been sought by using a "safe" volume of a solution of lower concentration. It has been shown by Kenepp, Cheek and Jutsche (1983) that, with the same total dose of infused bupivacaine, a 0.125% solution blocks more dermatomes than does either a 0.25% or 0.5% solution, possibly because a larger volume of fluid was infused. Clinical experience with the 0.125% concentration is inadequate as previous reports involved either a small number of patients or a short duration of infusion (less than 2 h) (Glover, 1977; Clark, 1982) . The present study was designed to assess the use of low concentrations of bupivacaine for extradural infusion in a controlled manner, and to determine the optimal volume of infusion necessary to prolong effectively the interval between top-ups received Hartmann's solution 500-1000 ml before the local anaesthetic was injected. Lumbar extradural blockade was performed via the L2-3 or L3-4 intervertebral space with a 16-gauge Tuohy needle. A catheter (Portex) was inserted leaving about 3-4 cm inside the extradural space. Ten millilitre of 0.5% bupivacaine was given initially and the effects assessed after 10-15 min. Solutions of 0.125% and 0.0625% bupivacaine were prepared by dilution of 0.5% bupivacaine 62.5 ml in physiological saline 187.5 ml and 0.5% bupivacaine 31.25 ml in physiological saline 218.75 ml, respectively. The patients were then randomly allocated to the following groups: Group I: control group with no infusion. Group II: 0.0625% bupivacaine infusion at 10 ml 1^(6.25 nigh" 1 ) Group III: 0.125% bupivacaine infusion at 5 ml h~' (6.25 m g h " 1 ) Group IV: 0.125% bupivacaine infusion at 10 ml I T 1 (12.5 mg h" 1 ) An additional group (group V) was added to determine whether a more rapid flow improved results: Group V: 0.125% bupivacaine infusion at 15 ml h~' (18.75 m g h " "
SUMMARY
The infusion was given by an IMED volumetric pump through a bacterial filter. At first, mothers were assessed every 60 min for the extent of sensory and motor blockade, but it became obvious that this was unnecessary, and assessment was carried out every 2 h. The sensory level was determined by pinprick and lower limb weakness graded on a scale from 0 to 3 (Bromage, 1978) . Arterial pressure was measured every 30 min and at 5-min intervals for 30 min following each top-up. The fetal heart was monitored continuously. If analgesia was considered inadequate by the mother, a top-up was given (0.25% bupivacaine 8-10 ml) and the time recorded. No special attempt was made to position the mother except to avoid aorto-caval compression.
At delivery, a top-up was administered if perineal analgesia was inadequate. The mode of delivery, duration of labour and condition of the baby were recorded. Venous blood samples were taken from the mother and from the umbilical cord for analysis of bupivacaine concentration. The samples were stored at -2 0 °C until analysed. Each mother was interviewed the day after delivery. The overall assessment of pain relief, degree of drowsiness and sickness experienced in labour were determined by 10-cm linear analogue scales. The durations of sensory and motor loss after delivery were noted. The condition of the baby was assessed by the mother and by the observer.
The results were analysed by t test, chi-square test with Yates' correction and one-way variance analysis. The intervals between top-ups were analysed by the log-rank test (see below). Ninety-eight primigravid mothers were included. Mothers with extradural blockade-delivery intervals of less than 3 h were excluded from the statistical analysis. There were no significant differences between any group of patients (including group V) in age, height, gestational period or birth weight (table I). The duration of the first stage of labour varied between a mean of 10.5 h and 12.9 h, and the mean durations of the second stage from 1.7 to 2.0 h (ns).
The mean interval between the induction of the extradural blockade and delivery ranged from 7.1 h to 8.6 h (ns), and the mean total dose used from 135.2 mg to 197.9 mg (P < 0.05) (table II). In only three patients did the total dose required exceed 300 mg: a mother in group II received 330 mg over 12 h; another in group III received 337 mg over 15 h; and a third in group V required 350 mg over 14 h. The mean dose per hour for each group showed a progressive increase in the amount of bupivacaine with increasing infusion dose (P < 0.005) (table II) . There were, however, no significant differences between the results in groups II and III, that is mothers who received the same total dose given in different concentrations.
Fifty-two per cent of primigravid mothers required three or more top-ups when no infusion was given, compared with 5% and 0% who had 0.125% bupivacaine 10 or lSmlrT 1 (table III) . Sixty-nine percent of mothers required none or only one top-up with an infusion of 0.125% bupivacaine 10 ml h . This compares favourably with 32% in the control group and 35% and 45% of the mothers receiving 6.25 mg h" 1 infusion (groups II and III, respectively). When the infusion rate was increased to 0.125% bupivacaine 15 ml h" 1 , the number who required one or less top-up increased to 70%. Only one mother who received an infusion at 12.5 mg h~' required more than two top-ups.
The time of each top-up was recorded and each interval representing the duration of adequate analgesia calculated. For most mothers in the period from the final dose to delivery, adequate analgesia was maintained right up to the time of delivery (and could have extended beyond this time). Some mothers had a top-up immediately before operative delivery. In those patients the last duration was discarded.
Cumulative percentage graphs were drawn for the durations of adequate analgesia for each infusion regimen ( fig. 1 ). This included all periods for each group, that is, several per subject. Groups were compared by the log-rank test (Peto et al., 1976 (Peto et al., , 1977 which was also used to examine variations between subjects within groups. In the control group the interval between top-ups varied between 25 min and 270 min with a median interval of 145 min. In the group receiving 0.0625% bupivacaine lOmlh" 1 , intervals varied between 90 min and 430 min (median duration of 190 min). In the group receiving 0.125% bupivacaine 5 ml h~', the interval between top-ups varied between 40 min and 462 min with a median interval of 195 min; these are similar means.
At an infusion rate of 0.125% bupivacaine 10 ml h ', the intervals varied between 38 min and 438 min with a median interval of 245 min. Variations between the first four groups were highly significant (chi-square = 22.65, d.f. = 3, P < 0.001). Variation between subjects was no greater than would be expected had each duration come from a different individual (chisquare = 71.02, d.f. = 74, ns). When the infusion rate of 0.125% bupivacaine was set at 15 ml h" 1 , the median interval of 265 min was not significantly different from that noted in those mothers receiving 0.125% bupivacaine 10 ml rT 1 .
Only one mother had a sensory block which extended up to T4 during infusion (table IV). The degree of lower limb paralysis did not vary greatly between groups. The mode of delivery was not related to the infusion regimen.
The overall pain, drowsiness and nausea scores at the postnatal interview (table V) showed no important differences. Babies were active and alert when examined on the second day. Only eight had any complication during delivery-all unrelated to extradural analgesia.
Excluding those from mothers who had the last top-up given for operative delivery (forceps and Caesarean section), 44 paired blood samples were available for bupivacaine analysis (table VI) . At delivery, venous bupivacaine concentrations were greater in those mothers who had an extradural infusion than in control subjects, and ranged from 0.325 \igm\~1 to 0.543 \igml~1. This difference was not statistically significant (P = 0.175). The bupivacaine concentration in the umbilical cord remained low both in controls and in mothers receiving the extradural infusion (P = 0.38).
DISCUSSION
In this study mothers with an extradural blockadedelivery interval of less than 3 h were excluded. This decision was taken since the initial loading dose could be effective within this period and would bias the results from the infusion; this was confirmed by the findings in the control group: 50% of mothers had adequate analgesia for over 2 h after a single extradural dose of bupivacaine. Therefore, previous studies in which an infusion was given for less than 2 h may not be valid (Evans and Carrie, 1979; Clark, 1982) . No special manipulation of the mother's posture was attempted. The physical behaviour of the infusion of bupivacaine in the extradural space is still far from clear (Bromage, 1978) . Frequent manipulation of labouring mothers causes excessive stress on the midwifery staff and inconvenience to the mothers. Time spent on frequent postural changes allowing infusions to "catch-up" could then be greater than giving top-ups in the usual way.
A continuous infusion of 0.125% bupivacaine 10 ml h" 1 resulted in 69% of these primigravid mothers requiring no or only one top-up. This is in agreement with the findings of Matouskova, Hanson and Elmen (1979) with 0.25% bupivacaine infused at 5 ml h ! . When the infusion rate was increased by 50% to 15 ml h" 1 , the percentage of success did not increase. This plateau of effect was also evident in the median intervals between topups.
In each test group the median duration between top-ups was 145, 190, 195, 245 and 265 min, respectively. A regression of the median interval between top-ups follows a straight line with increasing dose of infusion until a plateau is reached at the higher doses ( fig. 2 ). Therefore 0.125% bupivacaine 10 ml h" 1 appears optimal.
Considering results from mothers having the same dose but at different concentrations and volumes (group II and group III), the cumulative percentages ( fig. 1 ) of the two groups were very close and median durations of analgesia were 190 and 195 min, respectively. This indicates that more fluid in the extradural space did not provide longer analgesia and that the total dose of local anaesthetic was the decisive factor. This is in disagreement with the findings of Kenepp, Cheek and Gutsche (1983) that low concentrations of bupivacaine are more effective than higher concentrations in extradural infusion. This finding is in fact in agreement with Bromage's findings with the use of intermittent topups for continuous extradural analgesia (Bromage, 1978) .
The safety of continuous extradural infusion with local anaesthetics remains a matter of concern to anaesthetists. Inadvertent puncture of the dura during infusion has been recorded (Matouskova, Hanson and Elmen, 1979) . However, results from studies on bupivacaine used for subarachnoid analgesia give some indication of possible effects. After a bolus injection of 0.5% bupivacaine 15-20 mg, blockade usually does not extend above T4 (Chambers, Edstrom and Scott, 1981; Kalso, Tuominen and Rosenberg, 1982; Tuominen, Kalso and Rosenberg, 1982; Russell, i983; Ryan, Pridie and Copeland, 1983; Sheskey et al., 1983; Tattersall, 1983) . The block then regresses at about two segments per hour. Therefore, by infusing a dose of bupivacaine 12.5 mg h" 1 steadily, it is unlikely that total spinal blockade with respiratory paralysis would occur quickly (or even at all) if dural puncture occurred. There should be at least 2 h of warning before the blockade extended higher than T9-10 during obstetric analgesia. Sensory testing at T5-6 at 2-hourly intervals would detect advancing spinal blockade arising from inadvertent intrathecal infusion. In our series, admittedly small, only one patient had a block reaching T4, so that with this regimen there would have been only one false alarm with the proposed procedure. Therefore, it is advocated that testing the level at T5-6 (marked clearly) every 2 h during an infusion should be easily accepted by mid wives.
The bupivacaine concentrations in both mother and baby at delivery were well within the safety range of 1.5-2.3 \ig ml"' (Widman, 1966; Jorfeldt, et al., 1968; Hollmen, Kerhonen and Ojala, 1969; Reynolds and Taylor, 1971) . The higher maternal bupivacaine concentraton in the groups receiving an infusion probably related to the higher total dose used in these mothers. However, the umbilical cord bupivacaine concentration remained constantly low. This may be related to the higher protein-binding capacity of bupivacaine and the steady input of a small bupivacaine dose to the mother during infusion, compared with the high fluctuating concentration of intermittent top-ups. The results obtained agree with previous reports that the continuous extradural infusion of bupivacaine is safe for both mother and fetus (Glover, 1977; Evans and Carrie, 1979; Matouskova and Hanson, 1979; Clark, 1982) .
